Daiichi Sankyo has taken a step forward in expanding its interest in RNA-based t...
Pfizer and Arvinas reported that their estrogen receptor degrader failed to meet...
Merck has inaugurated a fresh $1 billion, 225,000-square-foot manufacturing site...
China-based Harbour BioMed has recently announced the establishment of a new bio...
The Durham complex of Merck now operates a new $1 billion, massive 225,000-squar...
Vori Health has secured $53m in a Series B funding round, supporting its value-b...
The two companies will work together on Zealand’s amylin analogue petrelintide a...
Entos Pharmaceuticals has announced an investment of C$62m ($43.05m) from the go...
WuXi XDC Cayman has signed a memorandum of understanding (MoU) with South Korea-...
The deal comes after a challenging few years for 2seventy bio, which had diveste...
The multi-year manufacturing deal with CordenPharma will secure future supply of...
Atsena Therapeutics has received fast track designation from the FDA for ATSN-20...
Europe’s drug regulatory agency has given Kizfizo a negative opinion for the sec...
Ono Pharmaceuticals has secured the global rights to sapablursen, an RNA-targeti...
The specialist in temperature-sensitive pharmaceutical shipments, is introducing...
Diabetes is a global health crisis that has reached alarming proportions, affect...
